ArticleNature communications2025

Targeting fibroblast derived thrombospondin 2 disrupts an immune-exclusionary environment at the tumor front in colorectal cancer.

Kosuke Iwane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.